FDA, Roche Warn on Counterfeit Avastin Entering U.S. Via Unauthorized Supplier

Counterfeit versions of Genentech’s cancer drug Avastin are circulating in the U.S. supply chain after 19 practitioners bought the drug from an unauthorized foreign supplier, the FDA and the Swiss-owned drugmaker warn. The FDA first learned of the suspect counterfeit Avastin (bevacizumab) from the UK Medicines and Healthcare products Regulatory Agency. It received additional information from Roche confirming the packaging was bogus and is now evaluating the scope of the issue.
Drug Industry Daily